Assessing Interventions That Prevent Multiple Infectious Diseases: Simple Methods for Multidisease Modeling

Anneke L. Claypool, Jeremy D. Goldhaber-Fiebert and Margaret L. Brandeau
Additional contact information
Anneke L. Claypool: Department of Management Science and Engineering, Stanford University, Stanford, CA, USA
Jeremy D. Goldhaber-Fiebert: Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA
Margaret L. Brandeau: Department of Management Science and Engineering, Stanford University, Stanford, CA, USA

Medical Decision Making, 2022, vol. 42, issue 4, 436-449

Abstract: Background Many cost-effectiveness analyses (CEAs) only consider outcomes for a single disease when comparing interventions that prevent or treat 1 disease (e.g., vaccination) to interventions that prevent or treat multiple diseases (e.g., vector control to prevent mosquito-borne diseases). An intervention targeted to a single disease may be preferred to a broader intervention in a single-disease model, but this conclusion might change if outcomes from the additional diseases were included. However, multidisease models are often complex and difficult to construct. Methods We present conditions for when multiple diseases should be considered in such a CEA. We propose methods for estimating health outcomes and costs associated with control of additional diseases using parallel single-disease models. Parallel modeling can incorporate competing mortality and coinfection from multiple diseases while maintaining model simplicity. We illustrate our approach with a CEA that compares a dengue vaccine, a chikungunya vaccine, and mosquito control via insecticide and mosquito nets, which can prevent dengue, chikungunya, Zika, and yellow fever. Results The parallel models and the multidisease model generated similar estimates of disease incidence and deaths with much less complexity. When using this method in our case study, considering only chikungunya and dengue, the preferred strategy was insecticide. A broader strategy—insecticide plus long-lasting insecticide-treated nets—was not preferred when Zika and yellow fever were included, suggesting the conclusion is robust even without the explicit inclusion of all affected diseases. Limitations Parallel modeling assumes independent probabilities of infection for each disease. Conclusions When multidisease effects are important, our parallel modeling method can be used to model multiple diseases accurately while avoiding additional complexity.

Keywords: coinfection; competing mortality; cost-effectiveness analysis; infectious disease; mathematical modeling (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X211033287 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:42:y:2022:i:4:p:436-449

DOI: 10.1177/0272989X211033287

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().